631.89

2.47% 15.26

Medpace Holdings Inc (MEDP)

Overview News Price History Option Chain Financials Discussions Forecast

Medpace Holdings Inc stock is traded at $631.89, with a volume of 204.98K. It is up +2.47% in the last 24 hours and up +1.84% over the past month. Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Previous Close:

$616.63

Open:

$622.83

24h Volume:

204.98K

Relative Volume:

0.88

Market Cap:

$17.64B

Revenue:

$2.68B

Net Income/Loss:

$460.40M

P/E Ratio:

39.75

EPS:

15.8963

Net Cash Flow:

$711.00M

1W Performance:

+4.84%

1M Performance:

+1.84%

6M Performance:

+21.86%

1Y Performance:

+22.86%

1-Day Range:

$617.60

$635.31

1-Week Range:

$602.70

$630.88

52-Week Range:

$373.00

$677.90

Medpace Holdings Inc Stock (MEDP) Company Profile

Name

Medpace Holdings Inc

Sector

Healthcare (1051)

Industry

Diagnostics & Research (44)

Phone

(513) 579-9911

Address

5375 MEDPACE WAY, CINCINNATI, OH

Employee

6,200

Twitter

@WorkatMedpace

Next Earnings Date

2026-10-21

Latest SEC Filings

MEDP's Discussions on Twitter

Compare MEDP vs TMO, DHR, NTRA, A, IQV

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MEDP Medpace Holdings Inc	631.89	17.64B	2.68B	460.40M	711.00M	15.90
TMO Thermo Fisher Scientific Inc	699.56	258.66B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	231.92	163.04B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	407.59	58.75B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	176.69	49.81B	7.23B	1.41B	1.09B	4.979
IQV Iqvia Holdings Inc	270.42	44.51B	16.63B	1.39B	2.12B	8.0674

Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-30-26	Resumed	UBS	Neutral
Jul-08-26	Downgrade	Robert W. Baird	Outperform → Neutral
Jul-07-26	Downgrade	Jefferies	Buy → Hold
Mar-06-26	Upgrade	Barclays	Underweight → Equal Weight
Mar-03-26	Initiated	RBC Capital Mkts	Outperform
Feb-18-26	Upgrade	TD Cowen	Sell → Hold
Feb-13-26	Upgrade	Jefferies	Hold → Buy
Feb-10-26	Upgrade	Robert W. Baird	Neutral → Outperform
Nov-13-25	Initiated	BMO Capital Markets	Market Perform
Oct-02-25	Downgrade	Barclays	Equal Weight → Underweight
Sep-03-25	Downgrade	Rothschild & Co Redburn	Buy → Neutral
Jul-29-25	Downgrade	UBS	Neutral → Sell
Jul-23-25	Downgrade	TD Cowen	Hold → Sell
Jun-24-25	Initiated	Barclays	Equal Weight
Apr-22-25	Downgrade	William Blair	Outperform → Mkt Perform
Apr-14-25	Downgrade	TD Cowen	Buy → Hold
Mar-24-25	Initiated	Leerink Partners	Market Perform
Oct-23-24	Downgrade	Robert W. Baird	Outperform → Neutral
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-27-24	Downgrade	UBS	Buy → Neutral
Sep-25-24	Downgrade	Jefferies	Buy → Hold
Aug-01-24	Initiated	Truist	Hold
May-29-24	Initiated	TD Cowen	Buy
May-28-24	Initiated	Mizuho	Buy
Apr-23-24	Upgrade	Jefferies	Hold → Buy
Mar-18-24	Initiated	Deutsche Bank	Hold
Feb-15-24	Upgrade	UBS	Neutral → Buy
Oct-24-23	Upgrade	Robert W. Baird	Neutral → Outperform
May-08-23	Upgrade	Guggenheim	Neutral → Buy
Oct-27-22	Upgrade	UBS	Sell → Neutral
Sep-07-22	Initiated	UBS	Sell
May-24-22	Initiated	Guggenheim	Neutral
Aug-05-21	Resumed	Credit Suisse	Outperform
Oct-02-20	Upgrade	Truist	Hold → Buy
Jun-08-20	Upgrade	Robert W. Baird	Underperform → Neutral
May-13-20	Downgrade	Wolfe Research	Outperform → Peer Perform
Apr-30-20	Upgrade	SunTrust	Sell → Hold
Apr-20-20	Downgrade	Robert W. Baird	Neutral → Underperform
Mar-17-20	Downgrade	SunTrust	Hold → Sell
Jan-27-20	Downgrade	SunTrust	Buy → Hold
Oct-31-18	Upgrade	SunTrust	Hold → Buy
Sep-17-18	Initiated	SunTrust	Hold
Jul-31-18	Upgrade	William Blair	Mkt Perform → Outperform
Nov-01-17	Downgrade	William Blair	Outperform → Mkt Perform
Sep-29-17	Initiated	Raymond James	Mkt Perform
Jul-10-17	Downgrade	KeyBanc Capital Mkts	Overweight → Sector Weight

View All

Medpace Holdings Inc Stock (MEDP) Latest News

Oct 14, 2026

CON vs. MEDP: Which Stock Should Value Investors Buy Now? - Zacks Investment Research

Oct 14, 2026

Oct 13, 2026

Medpace (MEDP) Dips More Than Broader Market: What You Should Know - Zacks Investment Research

Oct 13, 2026

Oct 06, 2026

Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors - Zacks Investment Research

Oct 06, 2026

Oct 02, 2026

After converting stock units into 28 shares, Medpace (MEDP) director McCarthy holds 12,303 shares directly. - Stock Titan

Oct 02, 2026

After a 32-share grant conversion, Medpace (MEDP) director Kraft holds 987 shares directly. - Stock Titan

Oct 02, 2026

After a 36-share conversion, Medpace (MEDP) director Carley holds 27,861 common shares. - Stock Titan

Oct 02, 2026

Medpace Holdings CEO August Troendle sells $30.3m in stock By Investing.com - Investing.com South Africa

Oct 02, 2026

Medpace Holdings CEO August Troendle sells $30.3m in stock By Investing.com - Investing.com Nigeria

Oct 02, 2026

Form 4 Medpace Holdings Inc For: 2 October By Investing.com - Investing.com Nigeria

Oct 02, 2026

Form 4 Medpace Holdings Inc For: 2 October By Investing.com - Investing.com South Africa

Oct 02, 2026

Medpace Holdings CEO August Troendle sells $30.3m in stock - Investing.com

Oct 02, 2026

Form 4 Medpace Holdings Inc For: 2 October By Investing.com - Investing.com Australia

Oct 02, 2026

Sep 30, 2026

Two days of CEO share sales at Medpace (MEDP) were executed through an open-window limit order. - Stock Titan

Sep 30, 2026

Sep 29, 2026

Medpace (MEDP) Rises As Market Takes a Dip: Key Facts - Zacks Investment Research

Sep 29, 2026

At about $620 a share, Medpace (MEDP) CEO sells stock on two dates: 2,410 shares and 154 shares - Stock Titan

Sep 29, 2026

Sep 28, 2026

Form 13D/A Medpace Holdings For: 28 September By Investing.com - Investing.com Nigeria

Sep 28, 2026

Sep 27, 2026

Medpace Holdings CEO August J. Troendle sells $6.75m in stock - Investing.com

Sep 27, 2026

Medpace Holdings CEO August Troendle sells $44.4m stock - Investing.com

Sep 27, 2026

Form 4 Medpace Holdings Inc For: 27 September By Investing.com - Investing.com India

Sep 27, 2026

Form 4 Medpace Holdings Inc For: 27 September By Investing.com - Investing.com UK

Sep 27, 2026

Sep 25, 2026

CEO sells shares on two days at Medpace (MEDP); a separate entry lists 4,733,019 indirectly held shares. - Stock Titan

Sep 25, 2026

Sep 24, 2026

After a 13,059-share sale, August Troendle reports a stake in Medpace (MEDP). - Stock Titan

Sep 24, 2026

Sep 23, 2026

Medpace (MEDP) CEO sold 49,018 shares on Sept. 22 at a $628.11 average price. - Stock Titan

Sep 23, 2026

MEDP FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important June 8 Deadline in Securities Class ActionMEDP - TMX Newsfile

Sep 23, 2026

Sep 22, 2026

MEDP DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Medpace Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class ActionMEDP - TMX Newsfile

Sep 22, 2026

Sep 21, 2026

Medpace (MEDP) Outperforms Broader Market: What You Need to Know - Zacks Investment Research

Sep 21, 2026

Medpace (NASDAQ: MEDP) CEO sells shares, holds 504,273 directly - stocktitan.net

Sep 21, 2026

Sep 18, 2026

Medpace Holdings, Inc.Common Stock (Nasdaq:MEDP) Price Chart - The Chronicle-Journal

Sep 18, 2026

Sep 17, 2026

Medpace Holdings (MEDP) CEO sells stock in two $620-range trades - stocktitan.net

Sep 17, 2026

Medpace Holdings (MEDP) insider exercises 3,000 options - stocktitan.net

Sep 17, 2026

Sep 11, 2026

Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 5 Years - Benzinga

Sep 11, 2026

Sep 10, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Medpace Holdings, Inc. (MEDP) And Encourages Shareholders to Reach Out - ACCESS Newswire

Sep 10, 2026

Sep 07, 2026